Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06266000Phase 4Completed
Phase 4, randomised, double-blind trial in lower urinary tract symptoms (LUTS) (3 arms), sponsored by RDC Clinical. Primary endpoints: Daily Urinary Frequency Log and International Prostate Symptom Score at Day 84. Started Jun 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06266000.